These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16506783)

  • 1. Potentials of mean force for acetylcholine unbinding from the alpha7 nicotinic acetylcholine receptor ligand-binding domain.
    Zhang D; Gullingsrud J; McCammon JA
    J Am Chem Soc; 2006 Mar; 128(9):3019-26. PubMed ID: 16506783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric structural motions of the homomeric alpha7 nicotinic receptor ligand binding domain revealed by molecular dynamics simulation.
    Henchman RH; Wang HL; Sine SM; Taylor P; McCammon JA
    Biophys J; 2003 Nov; 85(5):3007-18. PubMed ID: 14581202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein.
    Delbart F; Brams M; Gruss F; Noppen S; Peigneur S; Boland S; Chaltin P; Brandao-Neto J; von Delft F; Touw WG; Joosten RP; Liekens S; Tytgat J; Ulens C
    J Biol Chem; 2018 Feb; 293(7):2534-2545. PubMed ID: 29237730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor.
    Xiao Y; Hammond PS; Mazurov AA; Yohannes D
    J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of the unbinding pathway of α-conotoxin ImI from the α7 nicotinic acetylcholine receptor.
    Yu R; Kaas Q; Craik DJ
    J Phys Chem B; 2012 May; 116(21):6097-105. PubMed ID: 22571488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gating mechanism proposed from a simulation of a human alpha7 nicotinic acetylcholine receptor.
    Law RJ; Henchman RH; McCammon JA
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6813-8. PubMed ID: 15857954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creating an α7 nicotinic acetylcholine recognition domain from the acetylcholine-binding protein: crystallographic and ligand selectivity analyses.
    Nemecz Á; Taylor P
    J Biol Chem; 2011 Dec; 286(49):42555-42565. PubMed ID: 22009746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
    Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
    J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-induced conformational change in the alpha7 nicotinic receptor ligand binding domain.
    Henchman RH; Wang HL; Sine SM; Taylor P; McCammon JA
    Biophys J; 2005 Apr; 88(4):2564-76. PubMed ID: 15665135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular simulation study of the unbinding of α-conotoxin [ϒ4E]GID at the α7 and α4β2 neuronal nicotinic acetylcholine receptors.
    Suresh A; Hung A
    J Mol Graph Model; 2016 Nov; 70():109-121. PubMed ID: 27721068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying the binding site of novel methyllycaconitine (MLA) analogs at α4β2 nicotinic acetylcholine receptors.
    Quek GX; Lin D; Halliday JI; Absalom N; Ambrus JI; Thompson AJ; Lochner M; Lummis SC; McLeod MD; Chebib M
    ACS Chem Neurosci; 2010 Dec; 1(12):796-809. PubMed ID: 22778816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time tilting and twisting motions of ligand-bound states of α7 nicotinic acetylcholine receptor.
    Yang Y; Arai T; Sasaki D; Kuramochi M; Inagaki H; Ohashi S; Sekiguchi H; Mio K; Kubo T; Sasaki YC
    Eur Biophys J; 2024 Feb; 53(1-2):15-25. PubMed ID: 38233601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unbinding of nicotine from the acetylcholine binding protein: steered molecular dynamics simulations.
    Liu X; Xu Y; Wang X; Barrantes FJ; Jiang H
    J Phys Chem B; 2008 Apr; 112(13):4087-93. PubMed ID: 18327929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha7 nicotinic acetylcholine receptor: molecular modelling, electrostatics, and energetics.
    Amiri S; Tai K; Beckstein O; Biggin PC; Sansom MS
    Mol Membr Biol; 2005; 22(3):151-62. PubMed ID: 16096259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of acetylcholine binding site residues contributing to nicotinic acetylcholine receptor gating: role of residues Y93, Y190, K145 and D200.
    Mallipeddi PL; Pedersen SE; Briggs JM
    J Mol Graph Model; 2013 Jul; 44():145-54. PubMed ID: 23831994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the Binding Affinity by Jarzynski's Nonequilibrium Binding Free Energy and Rupture Time.
    Truong DT; Li MS
    J Phys Chem B; 2018 May; 122(17):4693-4699. PubMed ID: 29630379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites.
    Le Novère N; Grutter T; Changeux JP
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3210-5. PubMed ID: 11867716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
    Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted molecular dynamics study of C-loop closure and channel gating in nicotinic receptors.
    Cheng X; Wang H; Grant B; Sine SM; McCammon JA
    PLoS Comput Biol; 2006 Sep; 2(9):e134. PubMed ID: 17009865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topology of ligand binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Brain Res Brain Res Rev; 1997 Oct; 25(2):133-91. PubMed ID: 9403137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.